Drug Name:
ALAVERT ODT OTC
Generic Name and Formulations:
Loratadine 10mg; orally-disintegrating tabs; contains phenylalanine; fresh mint, citrus burst, bubble gum flavors.
Company:
Pfizer Inc.
Therapeutic Use:
Indications for ALAVERT ODT:
Allergic rhinitis (seasonal).
Adults and Children:
<6yrs: not recommended. ≥6yrs: Dissolve on tongue; swallow with or without water. 10mg once daily.
Warnings/Precautions:
Hepatic or renal impairment. Pregnancy. Nursing mothers.
Pharmacological Class:
Antihistamine.
Adverse Reactions:
Adults: headache, somnolence, fatigue, dry mouth. Children: nervousness, wheezing, hyperkinesia, abdominal pain, conjunctivitis, dysphonia, malaise, upper respiratory infections.
Metabolism:
Hepatic (CYP3A4, 2D6).
Elimination:
Renal, fecal.
Generic Availability:
YES
How Supplied:
ODT—12, 24, 48
Clinical Pain Advisor Articles
- Abuse-Deterrent Opioid Formulations: Barriers to Broader Use
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Medical Cannabis Legalization Associated With Reduced Schedule III Opioid Prescriptions
- Electroacupuncture May Help Reduce Opioid Use in Chronic Musculoskeletal Pain
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- Opioid Use Disorder Prevalence at Delivery on the Rise in the US, According to CDC
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Pharmacologically Induced Headache Accompanied by Dilated Cephalic Vessels
- IV Lidocaine May Be Safe, Efficacious for Pediatric Status Migraine
- Gray Matter Changes in Migraine Associated With Clinical Characteristics
